Modulation of oxidation-related immune markers by lipid-lowering medications in individuals with elevated lipoprotein(a)
In individuals with Lp(a) levels ≥ 75 nmol/L, high-intensity statins, add-on ezetimibe and add-on PCSK9i reduced IgG apoB-IC but did not affect IgM apoB-IC, or IgG and IgM anti-MDA-mimotope levels. The clinical significance of these findings warrants further investigation.
Authors
- Amalia Despoina Koutsogianni
- GEORGE LIAMIS
- Constantinos C. Tellis (ORCID: https://orcid.org/0000-0002-3959-1544)
- Sotirios Tsimikas
- Alexandros Tselepis
- Evangelos Liberopoulos
- Fotios Barkas
Institutions
- University of Ioannina (GR)
- University of California San Diego (US)
- Laiko General Hospital of Athens (GR)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1007/s00392-026-02896-5
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00